William Annett serves as Executive at OncoCyte Corp, where they oversee executive responsibilities. Since joining the company, William Annett has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 26, 2018 involved purchasing 3,500 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 26, 2018 | OCX | $0 | Purchase | 3,500 | $N/A | Discretionary |
William Annett currently holds 3,500 shares of OncoCyte Corp (OCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Annett has been a net neutral trader of OCX stock. They have purchased $0 and sold $0 worth of shares.
William Annett's most recent insider trade was on Jul 26, 2018, when they purchased 3,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted